Esomeprazole Market Set $2,872.07 Million By 2032, CAGR 5.3%

Esomeprazole Market Size Worth $2,872.07 Million By 2032 | CAGR: 5.3%

The global esomeprazole market size is expected to reach USD 2,872.07 million by 2032, according to a new study by Polaris Market Research. The report “Esomeprazole Market Share, Size, Trends, Industry Analysis Report, By Product (Capsules, Tablets, Injections, Others); By Application; By Distribution Channel; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Esomeprazole is gaining importance in the global healthcare space attributable to the prevalence of gastric ulcers, gastroesophageal reflux disease, Zollinger-Ellison syndrome, and more in the world. The higher effectiveness of esomeprazole in lowering acid in the stomach among humans is a contributing factor fueling the expansion of the esomeprazole market in the coming years.

The increasing gastrointestinal problems in people are showcasing the significant demand for esomeprazole, as it is widely utilized in the treatment process. According to the 2023 study, people infected with COVID-19 have a higher risk (39%) of developing gastroesophageal reflux disease in the year, followed by the infection in line with the people who are not infected by the COVID-19 virus. This study demonstrates new growth opportunities for the market during the study period.

The emergence of market players entering the production of esomeprazole in the marketplace is likely to enhance the esomeprazole market size in the coming years. For instance, in 2023, Granules India Limited received the approval of an abbreviated new drug application (ANDA) for Esomeprazole Magnesium delayed-release capsules for USP, 20 mg, and 40mg strengths from the US Food and Drug Administration (US FDA). These initiatives are expected to enhance the supply of this drug on the market.

Pharmaceutical companies are boosting research and development activities to innovate effective medication for the numerous unresolved health issues, including gastric and duodenal ulcers. For instance, in April 2023, Akums Drugs and Pharmaceuticals introduced the new Combikit for the treatment of H. pylori infection and duodenal ulcer. These developments are likely to create new esomeprazole market opportunities around the world.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below:

The increased accessibility of the internet lowered the chance of asymmetry of information in the world, driving enhanced knowledge of medicines. The rising stomach-related issues in the population are likely to facilitate significant demand for the esomeprazole drug through the over-the-counter option in the marketplace during the forecast period.

More companies are entering into the production of pharmaceutical drugs, specifically esomeprazole, driving the expansion of the global market. For instance, in October 2023, Marksans received approval to produce esomeprazole magnesium capsules.

Esomeprazole Market Report Highlights

  • Capsules segment is anticipated to witness the highest growth in the coming years due to its superior action over tablets.
  • Gastroesophageal reflux disease segment accounted for the largest market share owing to the rising incidence of acid reflux cases.
  • Hospitals & Clinical Pharmacies segment is projected to experience a larger revenue share attributable to the increased patient access.
  • APAC is projected to register the fastest growth during the forecast period attributable to the presence of the elderly population.
  • The global players include Actavis, AstraZeneca AB, Blaskov, CQ Lummy, KernPharm, Mepha, Mylan, Sandoz, Sanofi, Saval Pharmaceutical, Stada, & Teva.

Polaris Market Research has segmented the esomeprazole market report based on product, application, distribution channel and region:

Esomeprazole, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Capsules
  • Tablets
  • Injections
  • Others

Esomeprazole, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Gastroesophageal reflux disease
  • Erosive Esophagitis
  • Peptic Ulcers
  • Duodenal Ulcers
  • Zollinger-Ellison Syndrome
  • Others

Esomeprazole, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospitals & Clinical Pharmacies
  • Online Pharmacies
  • OTC

Esomeprazole, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa


Esomeprazole Market Report Scope

Report Attributes


Market size value in 2024

USD 1,904.40 million

Revenue forecast in 2032

USD 2,872.07 million


5.3% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD million and CAGR from 2024 to 2032

Segments covered

  • By Product
  • By Application
  • By Distribution Channel
  • By Region

Regional scope

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Competitive Landscape

  • Esomeprazole Market Share Analysis (2023)
  • Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

  • PDF + Excel


Report customization as per your requirements with respect to countries, region and segmentation.

For Specific Research Requirements

Request for Customized Report